C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) C07K 14/16 (2006.01) C12N 7/01 (2006.01) C12N 15/49 (2006.01) C12N 15/85 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01)
Patent
CA 2098029
Self-assembled, non-replicating, non-infectious retrovirus-like particles contain a chimeric envelope glycoprotein. The envelope glycoprotein comprises a first retroviral amino acid sequence which is substantially homologous with the native retrovirus amino acid sequence and a second retroviral amino acid sequence which is a heterologous amino acid sequence inserted into the first amino acid sequence. Such particles, which may comprise a retroviral surface glycoprotein sequence of HIV-1 or HTLV-1 inserted into the C2 conserved region of an HIV-1 isolate, generally elicit an immune response to at least the heterologous amino acid sequence, preferably both the first and second amino acid sequences.
Cao Shi Xian
Haynes Joel
Klein Michel Henri
Rovinski Benjamin
Aventis Pasteur Limited/aventis Pasteur Limitee
Zealey Gavin
LandOfFree
Retrovirus-like particles containing modified envelope... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retrovirus-like particles containing modified envelope..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retrovirus-like particles containing modified envelope... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021987